As of the latest SEC filings, BIOCRYST PHARMACEUTICALS INC (BCRX) is held by 238 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $76,309,007.04 in market value, representing a significant portion of its portfolio.
Funds holding BIOCRYST PHARMACEUTICALS INC (BCRX)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- BCRX
- CIK:
- 0000882796
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $76,309,007.04 | 8,015,652 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.85% | $63,356,114.08 | 6,655,054 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.07% | $52,837,904.00 | 5,550,200 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.02% | $27,552,060.48 | 2,894,124 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.03% | $25,555,449.92 | 2,684,396 | Mar 31, 2026 | May 28, 2026 |
|
VSEQX
VANGUARD STRATEGIC EQUITY FUND
|
MF | Vanguard | 0.21% | $21,468,294.96 | 2,255,073 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.06% | $20,468,184.88 | 2,234,518 | Apr 30, 2026 | Jun 26, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 1.74% | $19,838,927.92 | 2,083,921 | Mar 31, 2026 | May 29, 2026 |
|
THQ
abrdn Healthcare Opportunities Fund
|
CEF | abrdn / Aberdeen | 2.59% | $18,666,168.64 | 1,960,732 | Mar 31, 2026 | May 29, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.20% | $16,334,663.52 | 1,715,826 | Mar 31, 2026 | May 28, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.13% | $15,667,501.92 | 1,645,746 | Mar 31, 2026 | May 28, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.04% | $15,406,825.28 | 1,618,364 | Mar 31, 2026 | May 28, 2026 |
|
CALF
Pacer US Small Cap Cash Cows 100 ETF
|
ETF | Pacer | 0.41% | $14,257,485.04 | 1,556,494 | Apr 30, 2026 | Jun 29, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.06% | $12,285,886.64 | 1,341,254 | Apr 30, 2026 | Jun 26, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.03% | $10,852,091.25 | 1,240,239 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.07% | $10,137,977.50 | 1,158,626 | Feb 28, 2026 | Apr 28, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.05% | $10,047,345.00 | 1,148,268 | Feb 28, 2026 | Apr 24, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 1.69% | $9,482,081.84 | 996,017 | Mar 31, 2026 | May 29, 2026 |
|
TCSEX
Nuveen Quant Small Cap Equity Fund
|
MF | TIAA / Nuveen | 0.24% | $9,258,103.60 | 1,010,710 | Apr 30, 2026 | Jun 24, 2026 |
|
DFSTX
U.S. SMALL CAP PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.05% | $8,573,613.44 | 935,984 | Apr 30, 2026 | Jun 24, 2026 |
|
PBE
Invesco Biotechnology & Genome ETF
|
ETF | Invesco | 3.42% | $8,458,875.28 | 923,458 | Apr 30, 2026 | Jun 26, 2026 |
|
DFAS
Dimensional U.S. Small Cap ETF
|
ETF | Dimensional Fund Advisors | 0.05% | $7,383,848.52 | 806,097 | Apr 30, 2026 | Jun 29, 2026 |
|
BDSKX
BlackRock Advantage Small Cap Core Fund
|
MF | BlackRock / iShares | 0.16% | $7,304,193.75 | 834,765 | Feb 27, 2026 | Apr 24, 2026 |
|
VSTCX
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND
|
MF | Vanguard | 0.29% | $7,087,449.60 | 744,480 | Mar 31, 2026 | May 28, 2026 |
|
DFSCX
U.S. MICRO CAP PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.09% | $6,749,271.20 | 736,820 | Apr 30, 2026 | Jun 24, 2026 |
Advertisement (320x50)